The report analyzes the role of artificial intelligence (AI) and machine learning (ML) in transforming blood cancer therapeutics, with a focus on drug discovery, precision medicine, biomarker identification, and next-generation therapies such as CAR-T and bispecific antibodies. It also examines AI adoption by leading pharmaceutical companies and evaluates its impact on early diagnosis, treatment outcomes, and future therapeutic innovation.
The report includes:
- Impact analysis of artificial intelligence (AI) on the global market for blood cancer therapeutics
- Case studies for successful integration of AI, particularly machine learning (ML) and deep learning (DL) in enhanced treatment options and improved patient outcome
- Highlights of AI's impact across the major geographic regions and end-user industries
- Review of disruptions caused by AI across key industry verticals and the impact on various stages of global supply chain
- Competitive landscape featuring strategic initiatives, market spendings and VC funding outlook
Table of Contents
Chapter 1 Key Use Cases for AI Implementation- Overview
- Key Use Cases
- Use Case 1: Digital Twin
- Use Case 2: Personalized Approach
- Use Case 3: Real-World Patient Monitoring
- Overview
- Adoption Trends by Region
- Adoption Trends in North America
- Adoption Trends in Europe
- Adoption Trends in Asia-Pacific
- Adoption Trends in the Rest of the World
- Overview
- Impact of AI on Key Industry Verticals
- Lymphoma
- Leukemia
- Multiple Myeloma
- Impact of AI on Various Stages of the Value Chain
- Research and Development
- Streamlining Clinical Trials
- Manufacturing and Quality Control
- Biomarker Identification
- Overview
- Market Spending and Forecasting Analysis
- Key Spending by Blood Cancer Therapeutics Companies on AI
- Abbreviations Used in the Report
Table 1: Global Investment in Blood Cancer Therapeutics Market, 2024
Table 2: Key Spending by Companies on AI, 2025
Table 3: Abbreviations Used in This Report
List of Figures
Figure 1: Value Chain for the Global Blood Cancer Therapeutics Market
